Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announced Inclusion in AdvisorShares Psychedelics ETF; KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing

October 21, 2021 12:02:30
  • Tryp announced its inclusion in the AdvisorShares Psychedelics ETF
  • The company hopes that its participation will open it up to a more diverse shareholder base and broaden its life science exposure
  • Tryp’s presentation at the KCSA Virtual Investor Conference will also be available for on-demand viewing over the next 90 days
Launched back in September 2021, the AdvisorShares Psychedelics Exchange-Traded Fund (“ETF”) has been actively trading, focusing on enterprises that have devoted a significant proportion of their assets to psychedelic drug development. Operating under the ticker symbol “PSIL” on the New York Stock Exchange (“NYSE”) Arca exchange, this fund has built a portfolio that includes over 25 different psychedelic companies. Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is the latest addition to that group. Tryp is excited with its inclusion in the fund, particularly since it provides an opportunity to bring a more diverse shareholder base while also broadening life science exposure for the company ( Its operations and commitment to developing psilocybin-based compounds for ailments with high unmet medical needs line up with AdvisorShares ETF’s main objective and focus. Interested parties can now also access Tryp’s KCSA Psychedelics Virtual Investor Conference presentation. In partnership with KCSA Strategic Communications, Virtual Investor Conferences announced that this and other presentations from critical players within the psychedelics space are now available for on-demand viewing ( The two-day event, held on October 13-14, 2021, featured a live overview of Tryp’s activities while elaborating on how it is leading the next wave of psychedelic drug development beyond mental health, focusing on chronic pain and other indications ( These presentations will be available 24/7 over the next 90 days. Interested parties, analysts, investors, and advisors can also download shareholder materials from the company’s “virtual trade booth.” For those who wish to access the presentations, you can register or log in now at For more information, visit the company’s website at NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at About PsychedelicNewsWire PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics. To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only) For more information please visit Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: Do you have questions or are you interested in working with PNW? Ask our Editor PsychedelicNewsWire (PNW) San Francisco, California 415.949.5050 Office PsychedelicNewsWire is part of the InvestorBrandNetwork.